Repligen | RGEN - Assets

Stock Price
147.29
Daily Change
-2.94 -1.96%
Monthly
-13.07%
Yearly
-9.04%
Q1 Forecast
144.77

Repligen reported $2.92B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agilent USD 12.73B 501M Sep/2025
Align Technology USD 6.23B 14.46M Sep/2025
Bio Techne USD 2.52B 3.45M Dec/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Bruker USD 6.43B 95.1M Sep/2025
Charles River Laboratories USD 7.51B 46.73M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.65B 416M Sep/2025
Exact Sciences USD 5.9B 102.64M Sep/2025
General Electric Aerospace USD 130.17B 1.93B Dec/2025
Henry Schein USD 11.1B 191M Sep/2025
Illumina USD 6.18B 90M Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Mettler Toledo International USD 3.52B 121M Sep/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Repligen USD 2.92B 22.08M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Standard Biotools USD 539.64M 17.32M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Waters USD 4.86B 144.49M Sep/2025
West Pharmaceutical Services USD 4.11B 153M Sep/2025